Navigation Links
Link Uncovered Between Benign Prostatic Hyperplasia and NSAIDs, Says Harvard Men's Health Watch
Date:9/5/2007

BOSTON, Sept. 5 /PRNewswire-USNewswire/ -- Men with slow urine flow from enlargement of the prostate gland (known as benign prostatic hyperplasia or BPH) should avoid anything that makes the situation worse--and that includes some medications. The most common offenders are over-the-counter cold and allergy remedies. Now, some research suggests that nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, may also affect the prostate's function, reports the September 2007 issue of Harvard Men's Health Watch.

Researchers in the Netherlands found that the risk of acute urinary retention (severe difficulty urinating) was twice as high in men taking NSAIDs as in men who were not using them. By contrast, though, researchers in America evaluating the long-term effects of NSAIDs on the prostate found that daily NSAID use was linked to a reduced risk of developing BPH symptoms and slow urinary flow rates.

At first glance the studies seem contradictory, but a closer look suggests that NSAIDs may be both friend and foe, depending on the stage of BPH and the part of the urinary tract that's vulnerable.

The American study evaluated the onset of BPH symptoms. There is emerging evidence that inflammation may play a role in development of BPH. If that's the case, regular NSAID use might delay the onset of symptoms. The Dutch study, which evaluated established cases of acute urinary retention, found that men who had recently begun taking NSAIDs were at the highest risk. These men may already have been developing BPH for years before taking the NSAIDs. And the NSAIDs may have caused trouble by acting on the bladder, not the prostate.

Harvard Men's Health Watch suggests that if men notice an increase in BPH symptoms while taking an NSAID, they should inform their doctors and reduce or avoid NSAIDs.

Also in this issue:

-- How to increase "good" cholesterol

-- Help for restless legs syndrome

-- MRIs and stents: Incompatible?

Harvard Men's Health Watch is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $24 per year. Subscribe at http://www.health.harvard.edu/men or by calling 1-877-649-9457 (toll free).

Media: Contact Christine Junge at Christine_Junge@hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.


'/>"/>
SOURCE Harvard Men's Health Watch
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mystery behind Preeclampsia uncovered
2. Syphilis uncovered
3. Mystery of nacrolepsy uncovered
4. Hospitals Health Insurance Scam Uncovered
5. Grapefruit juice could be taken along with medication: the nutrient-drug reaction uncovered!
6. New Diagnostic Tool Uncovered Gene Expression Patterns in Recessive Genetic Disorders
7. Elusive Step In DNA Mutation Uncovered By Researchers
8. Brains Filing System Uncovered
9. The Anti-HIV Properties Of Green Tea Uncovered
10. CDC reveals relationship between prepregnant weight and heart defects in infants
11. Link between Constipation and Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the ... affiliation with Tennessee Counseling Association. This new relationship allows TherapySites to ... Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: